North American schizophrenia drugs market is projected to grow at a significant CAGR of 2.1% during the forecast period. The increasing incidence of anxiety disorders in North America is generating the demand for different types of medication and therapies for its treatment and thereby is expected to propel the growth of the schizophrenia drugs market in the region. The incorporation of anti-stress programs including yoga, therapy, Employee Assistance Program (EAPs), social activities, childcare initiatives, provision of work from home, flexible timings, and mindfulness training are some other factors that can make a significant contribution to the schizophrenia drugs market growth in the region.
A full report of North American Schizophrenia Drugs Market is available at: https://www.omrglobal.com/industry-reports/north-american-schizophrenia-drugs-market
In addition to the rising prevalence of major depressive disorders and anxiety disorders, the high prevalence of PTSD in the US is further supporting the growth of the schizophrenia drugs market. The National Centre for PTSD offers mobile applications (apps) including self-help, companion apps, and other apps. The different self-help apps for monitoring of PTSD include PTSD Family Coach, Mindfulness Coach, VetChange, and AIMS. The treatment companion apps offered by the National Centre for PTSD, for use with a health care provider to make treatment easier include CPT Coach, PE Coach, CBT-iCoach, ACT Coach, and Stagecoach. Other apps for monitoring of related disorders include Mood Coach, Concussion Coach, Parenting2Go, Moving Forward, and Stay Quit Coach. These apps work on both the iOS and Android devices. In addition, the National Centre for PTSD offers online programs including PTSD coach online, VetChange, community reinforcement and family training-post trauma stress disorder (CRAFT-PTSD), community reinforcement and family training-substance use disorder (CRAFT-SUD).
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/north-american-schizophrenia-drugs-market
Market Coverage
- The market number available for – 2019-2026
- Base year- 2019
- Forecast period- 2020-2026
- Segments Covered
- By Therapeutic Class
- By Treatment
- Countries Covered
- US
- Canada
- Allergan PLC, Catalent, Inc., Otsuka Pharmaceutical Co., Ltd., Eli Lilly and Co., AstraZeneca PLC, and Johnson & Johnson Services, Inc.
Key questions addressed by the report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market during the forecast period?
- How COVID-19 will impact the market growth in 2020 and coming years?
- Recovery Timeline
- Deviation from pre-COVID-19
- Most affected region/segment
- Recommendations
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
North American Schizophrenia Drugs Market – Segmentation
By Therapeutic Class
- Second Generation Antipsychotics
- Third Generation Antipsychotics
- Others (First Generation Antipsychotics)
By Treatment
- Oral
- Injectables
North American Schizophrenia Drugs Market – Segmentation by Geography
- United States
- Canada
Company Profiles
- Alkermes PLC
- Allergan PLC
- AstraZeneca PLC
- Biogen Inc.
- Catalent, Inc.
- Eli Lilly and Co.
- Lundbeck A/S
- Indivior PLC
- Johnson & Johnson Services, Inc.
- Lupin Ltd.
- Merck & Co., Inc.
- Minerva Neurosciences, Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Pfizer Inc.
- Sunovion Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
